Clinical Trial Update: A Safety and Efficacy Study of Enzalutamide in Indian Patients With Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel-Based Chemotherapy [Phase 4]

View source ↗

Summary

Phase 4 safety and efficacy results for enzalutamide in Indian patients with metastatic castration-resistant prostate cancer previously treated with docetaxel h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Xtandi (enzalutamide)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Metastatic Castration Resistant Prostate Cancer | Phase 4 | Status: COMPLETED | Results posted: 2025-01-23